| Pharmaceutical active ingredients: |
| Morpholine Salicylate |
| Available forms, composition and doses of Deposal: |
| N / A |
| Deposal medical category: |
| Human:Musculoskeletal disorders treatment drugsSalicylic acid derivatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02BA08 - Morpholine salicylate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Neoterapici Benvegna |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Depo-Promone | Medroxyprogesterone | Unidentified Pharmaceutical Company |
| Depoprovera | Medroxyprogesterone Acetate | Pfizer |
| Depo-Provera | Medroxyprogesterone Acetate | Pfizer; Max India; Primal Chemical; The Glory Medicina; Zuellig Pharma |
| Depo-Ralovera | Medroxyprogesterone Acetate | Pfizer |
| Deporeva | Medroxyprogesterone Acetate | Elder Pharmaceuticals; QB International Trade |
| Deposet | Methylprednisolone Aceponate | VHB Lifesciences |
| Deposiston | Ethinyl Estradiol Propane Sulfonate; Norethindrone Acetate | Jenapharm |
| Depostat | Gestonorone Caproate | Bayer Schering Pharma; Cambridge Laboratories |
| Deposteron | Testosterone Cypionate | Novaquimica Sigma Pharma-Nature's Plus |
| Depo-SubQ Provera | Medroxyprogesterone Acetate | Pfizer |